Home › Heart Failure › NCT06461962
Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patient-defined regular use of methamphetamine in the last year * Any methamphetamine use in the past 30 days * Age 18 years or older * No client-reported diagnosis of heart failure * Able to communicate in English * Screen positive for potential methamphetamine-associated heart failure (MAHF) defined as B type natriuretic peptide (BNP) ≥50 pg/ml, or QRS width ≥120ms, or presence of any clinical heart failure symptoms Exclusion Criteria: * Self-reported engagement in medical care for heart failure in past 6 months. * Actively taking medications for heart failure.
About the study
The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.
What is being tested
- Treatment as Usual (other)
- Telehealth-Cardiology (other)
Sponsor: Oregon Health and Science University · Participants: 200 · Started: Aug 19, 2024
Contact the study team
- Brian Chan, MD, MPH · Phone: 503-494-2010
Official record on ClinicalTrials.gov — NCT06461962
Locations in the U.S.
| Oregon | Oregon Health & Science University, Portland |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.